Martin Huber
Chief Executive Officer at MERSANA THERAPEUTICS, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Martin H.
Huber is currently the President, Chief Executive Officer & Director at Mersana Therapeutics, Inc. since 2023.
He is also an Independent Director at Syndax Pharmaceuticals, Inc. since 2021.
Previously, he held positions such as Vice President-Global Pharmacovigilance at Schering-Plough Corp.
and Chief Medical Officer & Senior Vice President at Tesaro, Inc. from 2015 to 2019.
He was also the Senior Vice President-Clinical at GSK Plc from 2019 to 2020.
Additionally, he served as an Assistant Professor at The University of Texas M.D.
Anderson Cancer Center and Vice President-Oncology Clinical Research at Merck Research Laboratories Massachusetts LLC from 2012 to 2015.
Dr. Huber's education includes an undergraduate degree from Texas Lutheran University and a doctorate from Baylor College of Medicine.
His current job(s) include President, Chief Executive Officer & Director at Mersana Therapeutics, Inc. and Independent Director at Syndax Pharmaceuticals, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-07 | 48,000 ( 0.06% ) | 1 M $ | 2024-03-30 | |
| 2024-01-14 | 14,467 ( 0.01% ) | 64 812 $ | 2024-03-30 | |
XILIO THERAPEUTICS INC
-.--% | 2023-08-15 | 0 ( -.--% ) | - $ | 2024-03-30 |
Martin Huber active positions
| Companies | Position | Start |
|---|---|---|
| MERSANA THERAPEUTICS, INC. | Chief Executive Officer | 2023-09-10 |
| SYNDAX PHARMACEUTICALS, INC. | Director/Board Member | 2021-09-14 |
Former positions of Martin Huber
| Companies | Position | End |
|---|---|---|
| XILIO THERAPEUTICS, INC. | President | 2023-09-07 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 2020-03-31 |
| TESARO INC | Chief Tech/Sci/R&D Officer | 2019-01-21 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | 2014-12-31 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 2009-11-03 |
Training of Martin Huber
| Texas Lutheran University | Undergraduate Degree |
| Baylor College of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
- Stock Market
- Insiders
- Martin Huber
